RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Luis M. Vilá to Adult

Back to Details
This is a "connection" page, showing publications Luis M. Vilá has written about Adult.
Luis M. Vilá
Connection Strength
1.427
Adult
  1. Medina-Cintr?n N, Mart?nez I, P?rez-R?os N, Berr?os-L?pez Y, Vil? LM. Clinical Manifestations and Outcomes in Disease-Modifying Antirheumatic Drug-Naive Adult Patients with Chronic Chikungunya Arthritis. Am J Trop Med Hyg. 2021 03 08; 104(5):1741-1746.
    View in: PubMed
    Score: 0.068
  2. V?zquez-Otero I, Medina-Cintr?n N, Arroyo-?vila M, Gonz?lez-Sep?lveda L, Vil? LM. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus. Lupus Sci Med. 2020 05; 7(1).
    View in: PubMed
    Score: 0.064
  3. Gago R, Shum LM, Vil? LM. Right upper quadrant abdominal pain as the initial presentation of polyarteritis nodosa. BMJ Case Rep. 2017 Feb 22; 2017.
    View in: PubMed
    Score: 0.051
  4. Arroyo-?vila M, Cab?n A, Garc?a-Rivera EJ, Irizarry-P?rez M, Torres H, Gorbea H, Vil? LM. Clinical Manifestations Associated with Peripheral Joint Involvement in Patients with Acute Chikungunya Virus Infection. Am J Trop Med Hyg. 2017 Apr; 96(4):916-921.
    View in: PubMed
    Score: 0.051
  5. Fred-Jim?nez RM, Arroyo-?vila M, Mayor ?M, R?os G, Vil? LM. Clinical Manifestations Associated with Overweight/Obesity in Puerto Ricans with Fibromyalgia Syndrome. J Obes. 2016; 2016:1379289.
    View in: PubMed
    Score: 0.048
  6. V?zquez-Sanabria IL, Mercado-Seda R, Varela-Rosario N, Vil? LM. Efficacy of intravenous immunoglobulins in a patient with systemic lupus erythematosus presenting with Stevens-Johnson syndrome. BMJ Case Rep. 2015 Jul 22; 2015.
    View in: PubMed
    Score: 0.046
  7. R?os G, Estrada M, Mayor AM, Vil? LM. Factors associated with tender point count in Puerto Ricans with fibromyalgia syndrome. P R Health Sci J. 2014 Sep; 33(3):112-6.
    View in: PubMed
    Score: 0.043
  8. Font YM, Castro-Santana LE, Nieves-Plaza M, Maldonado M, Mayor AM, Vil? LM. Factors associated with regional rheumatic pain disorders in a population of Puerto Ricans with diabetes mellitus. Clin Rheumatol. 2014 Jul; 33(7):995-1000.
    View in: PubMed
    Score: 0.042
  9. Fajardo-Hermosillo LD, Rodr?guez-Navedo Y, Nadal AJ, Vil? LM. Lymphocyte sensitivity assay as a marker for glucocorticoid resistance in lupus: report of two sisters with systemic lupus erythematosus. Lupus. 2014; 23(1):88-92.
    View in: PubMed
    Score: 0.041
  10. Rodr?guez-P?rez N, Rodr?guez-Navedo Y, Font YM, Vil? LM. Inflammatory myopathy as the initial presentation of cryoglobulinaemic vasculitis. BMJ Case Rep. 2013 Jun 03; 2013.
    View in: PubMed
    Score: 0.040
  11. Fajardo-Hermosillo LD, L?pez-L?pez L, Nadal A, Vil? LM. Multifocal osteonecrosis in systemic lupus erythematosus: case report and review of the literature. BMJ Case Rep. 2013 Apr 16; 2013.
    View in: PubMed
    Score: 0.039
  12. Negr?n AM, D?az-Correa LM, Gago R, Mayor AM, Mart?nez A, Vil? S, Vil? LM. Rheumatology practice profiles in teaching and community settings in Puerto Rico: implications to subspecialty training. J Clin Rheumatol. 2013 Mar; 19(2):67-71.
    View in: PubMed
    Score: 0.039
  13. Santiago-Casas Y, Peredo RA, Vil? LM. Efficacy of low-dose intravenous cyclophosphamide in systemic lupus erythematosus presenting with Guillain-Barre syndrome-like acute axonal neuropathies: report of two cases. Lupus. 2013 Mar; 22(3):324-7.
    View in: PubMed
    Score: 0.039
  14. Santiago-Casas Y, Gonz?lez-Rivera T, Castro-Santana L, R?os G, Mart?nez D, Rodr?guez V, Gonz?lez-Alcover R, Mayor AM, Vil? LM. Impact of managed care health insurance system for indigent patients with rheumatoid arthritis in Puerto Rico. Clin Rheumatol. 2013 Jun; 32(6):763-9.
    View in: PubMed
    Score: 0.039
  15. Nieves-Plaza M, Castro-Santana LE, Font YM, Mayor AM, Vil? LM. Association of hand or knee osteoarthritis with diabetes mellitus in a population of Hispanics from Puerto Rico. J Clin Rheumatol. 2013 Jan; 19(1):1-6.
    View in: PubMed
    Score: 0.038
  16. Nieves-Plaza M, Ortiz AP, Col?n M, Molina MJ, Castro-Santana LE, Rodr?guez VE, Mayor AM, Vil? LM. Outcome and predictors of kidney disease progression in Puerto Ricans with systemic lupus erythematosus initially presenting with mild renal involvement. J Clin Rheumatol. 2011 Jun; 17(4):179-84.
    View in: PubMed
    Score: 0.034
  17. Burgos PI, McGwin G, Pons-Estel GJ, Reveille JD, Alarc?n GS, Vil? LM. US patients of Hispanic and African ancestry develop lupus nephritis early in the disease course: data from LUMINA, a multiethnic US cohort (LUMINA LXXIV). Ann Rheum Dis. 2011 Feb; 70(2):393-4.
    View in: PubMed
    Score: 0.032
  18. Castro-Santana LE, Col?n M, Molina MJ, Rodr?guez VE, Mayor AM, Vil? LM. Efficacy of two cyclophosphamide regimens for the treatment of lupus nephritis in Puerto Ricans: low vs. standard dose. Ethn Dis. 2010; 20(1 Suppl 1):S1-116-21.
    View in: PubMed
    Score: 0.031
  19. Santiago-Casas Y, Gonz?lez-Rivera TC, Castro-Santana LE, R?os G, Mart?nez D, Rodr?guez VE, Gonz?lez-Alcover R, Mayor AM, Vil? LM. Impact of age on clinical manifestations and outcome in Puerto Ricans with rheumatoid arthritis. Ethn Dis. 2010; 20(1 Suppl 1):S1-191-5.
    View in: PubMed
    Score: 0.031
  20. Burgos PI, Alarc?n GS, McGwin G, Crews KQ, Reveille JD, Vil? LM. Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII. Arthritis Rheum. 2009 Sep 15; 61(9):1179-86.
    View in: PubMed
    Score: 0.031
  21. Molina MJ, Mayor AM, Franco AE, Morell CA, L?pez MA, Vil? LM. Utilization of health services and prescription patterns among lupus patients followed by primary care physicians and rheumatologists in Puerto Rico. Ethn Dis. 2008; 18(2 Suppl 2):S2-205-10.
    View in: PubMed
    Score: 0.027
  22. Molina MJ, Mayor AM, Franco AE, Morell CA, L?pez MA, Vil? LM. Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico. J Clin Rheumatol. 2007 Aug; 13(4):202-4.
    View in: PubMed
    Score: 0.026
  23. Vil? LM, Alarc?n GS, McGwin G, Bastian HM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum. 2006 Oct 15; 55(5):799-806.
    View in: PubMed
    Score: 0.025
  24. Col?n-Soto M, Peredo RA, Vil? LM. Systemic lupus erythematosus after mesotherapy with acetyl-L-carnitine. J Clin Rheumatol. 2006 Oct; 12(5):261-2.
    View in: PubMed
    Score: 0.025
  25. Vil? LM, Molina MJ, Mayor AM, Cruz JJ, R?os-Olivares E, R?os Z. Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus. Clin Rheumatol. 2007 May; 26(5):718-22.
    View in: PubMed
    Score: 0.025
  26. Vil? LM, Alarc?n GS, McGwin G, Bastian HM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol. 2005 Nov; 32(11):2150-5.
    View in: PubMed
    Score: 0.023
  27. Amaral JK, Bingham CO, Taylor PC, Vil? LM, Weinblatt ME, Schoen RT. Therapy for Chikungunya Arthritis: A Study of 133 Brazilian Patients. Am J Trop Med Hyg. 2023 09 06; 109(3):542-547.
    View in: PubMed
    Score: 0.020
  28. Borgia RE, Ugarte-Gil MF, Vil? LM, Reveille JD, McGwin G, Alarc?n GS. Health-Related Quality of Life in Adults With Adolescent- and Adult-Onset Systemic Lupus Erythematosus: A Longitudinal Study of a Multiethnic US Cohort. Arthritis Care Res (Hoboken). 2023 07; 75(7):1416-1422.
    View in: PubMed
    Score: 0.019
  29. Ugarte-Gil MF, Dubey J, McGwin G, Reveille JD, Vil? LM, Alarc?n GS. Association of Systemic Lupus International Collaborating Clinics Frailty Index With Damage in Systemic Lupus Erythematosus Patients: Results From a Multiethnic, Multicenter US Cohort of Patients With Lupus. Arthritis Care Res (Hoboken). 2023 03; 75(3):585-589.
    View in: PubMed
    Score: 0.019
  30. Ugarte-Gil MF, Pons-Estel GJ, Harvey GB, Vil? LM, Griffin R, Alarc?n GS. Applying the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Lupus Criteria to Patients From the LUMINA Cohort: Results From the Multiethnic, Multicenter US Cohort. Arthritis Care Res (Hoboken). 2021 10; 73(10):1451-1455.
    View in: PubMed
    Score: 0.018
  31. Jolly M, Sehgal V, Arora S, Azizoddin D, Pinto B, Sharma A, Devilliers H, Inoue M, Toloza S, Bertoli A, Blazevic I, Vil? LM, Moldovan I, Torralba KD, Mazzoni D, Cicognani E, Hasni S, Goker B, Haznedaroglu S, Bourre-Tessier J, Navarra SV, Clarke A, Weisman M, Wallace D, Mok CC. Does hydroxychloroquine improve patient reported outcomes in patients with lupus? Lupus. 2021 Oct; 30(11):1790-1798.
    View in: PubMed
    Score: 0.017
  32. Arroyo-?vila M, Santiago-Casas Y, McGwin G, Cantor RS, Petri M, Ramsey-Goldman R, Reveille JD, Kimberly RP, Alarc?n GS, Vil? LM, Brown EE. Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort. Clin Rheumatol. 2015 Jul; 34(7):1217-23.
    View in: PubMed
    Score: 0.011
  33. Martins M, Williams AH, Comeau M, Marion M, Ziegler JT, Freedman BI, Merrill JT, Glenn SB, Kelly JA, Sivils KM, James JA, Guthridge JM, Alarc?n-Riquelme ME, Bae SC, Kim JH, Kim D, Anaya JM, Boackle SA, Criswell LA, Kimberly RP, Alarc?n GS, Brown EE, Vil? LM, Petri MA, Ramsey-Goldman R, Niewold TB, Tsao BP, Gilkeson GS, Kamen DL, Jacob CO, Stevens AM, Gaffney PM, Harley JB, Langefeld CD, Fesel C. Genetic association of CD247 (CD3?) with SLE in a large-scale multiethnic study. Genes Immun. 2015 Mar; 16(2):142-50.
    View in: PubMed
    Score: 0.011
  34. Zhao J, Giles BM, Taylor RL, Yette GA, Lough KM, Ng HL, Abraham LJ, Wu H, Kelly JA, Glenn SB, Adler AJ, Williams AH, Comeau ME, Ziegler JT, Marion M, Alarc?n-Riquelme ME, Alarc?n GS, Anaya JM, Bae SC, Kim D, Lee HS, Criswell LA, Freedman BI, Gilkeson GS, Guthridge JM, Jacob CO, James JA, Kamen DL, Merrill JT, Sivils KM, Niewold TB, Petri MA, Ramsey-Goldman R, Reveille JD, Scofield RH, Stevens AM, Vil? LM, Vyse TJ, Kaufman KM, Harley JB, Langefeld CD, Gaffney PM, Brown EE, Edberg JC, Kimberly RP, Ulgiati D, Tsao BP, Boackle SA. Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Ann Rheum Dis. 2016 Jan; 75(1):242-52.
    View in: PubMed
    Score: 0.011
  35. Kaiser R, Tang LF, Taylor KE, Sterba K, Nititham J, Brown EE, Edberg JC, McGwin G, Alarc?n GS, Ramsey-Goldman R, Reveille JD, Vil? LM, Petri M, Rauch J, Miller E, Mesznik K, Kwok PY, Kimberly RP, Salmon JE, Criswell LA. A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus. Arthritis Rheumatol. 2014 Jul; 66(7):1882-7.
    View in: PubMed
    Score: 0.011
  36. L?pez-L?pez L, Nieves-Plaza M, Castro Mdel R, Font YM, Torres-Ramos CA, Vil? LM, Ayala-Pe?a S. Mitochondrial DNA damage is associated with damage accrual and disease duration in patients with systemic lupus erythematosus. Lupus. 2014 Oct; 23(11):1133-41.
    View in: PubMed
    Score: 0.011
  37. Ramos PS, Oates JC, Kamen DL, Williams AH, Gaffney PM, Kelly JA, Kaufman KM, Kimberly RP, Niewold TB, Jacob CO, Tsao BP, Alarc?n GS, Brown EE, Edberg JC, Petri MA, Ramsey-Goldman R, Reveille JD, Vil? LM, James JA, Guthridge JM, Merrill JT, Boackle SA, Freedman BI, Scofield RH, Stevens AM, Vyse TJ, Criswell LA, Moser KL, Alarc?n-Riquelme ME, Langefeld CD, Harley JB, Gilkeson GS. Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry. J Rheumatol. 2013 Jun; 40(6):842-9.
    View in: PubMed
    Score: 0.010
  38. Kaiser R, Taylor KE, Deng Y, Zhao J, Li Y, Nititham J, Chang M, Catanese J, Begovich AB, Brown EE, Edberg JC, McGwin G, Alarc?n GS, Ramsey-Goldman R, Reveille JD, Vila LM, Petri M, Kimberly RP, Feng X, Sun L, Shen N, Li W, Lu JX, Wakeland EK, Li QZ, Yang W, Lau YL, Liu FL, Chang DM, Yu CY, Song YW, Tsao BP, Criswell LA. Brief Report: Single-nucleotide polymorphisms in VKORC1 are risk factors for systemic lupus erythematosus in Asians. Arthritis Rheum. 2013 Jan; 65(1):211-5.
    View in: PubMed
    Score: 0.010
  39. S?nchez E, Rasmussen A, Riba L, Acevedo-Vasquez E, Kelly JA, Langefeld CD, Williams AH, Ziegler JT, Comeau ME, Marion MC, Garc?a-De La Torre I, Maradiaga-Cece?a MA, Cardiel MH, Esquivel-Valerio JA, Rodriguez-Amado J, Moctezuma JF, Miranda P, Perandones CE, Castel C, Laborde HA, Alba P, Musuruana JL, Goecke IA, Anaya JM, Kaufman KM, Adler A, Glenn SB, Brown EE, Alarc?n GS, Kimberly RP, Edberg JC, Vil? LM, Criswell LA, Gilkeson GS, Niewold TB, Mart?n J, Vyse TJ, Boackle SA, Ramsey-Goldman R, Scofield RH, Petri M, Merrill JT, Reveille JD, Tsao BP, Orozco L, Baca V, Moser KL, Gaffney PM, James JA, Harley JB, Tusi?-Luna T, Pons-Estel BA, Jacob CO, Alarc?n-Riquelme ME. Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis Rheum. 2012 Nov; 64(11):3687-94.
    View in: PubMed
    Score: 0.010
  40. Kaiser R, Li Y, Chang M, Catanese J, Begovich AB, Brown EE, Edberg JC, McGwin G, Alarc?n GS, Ramsey-Goldman R, Reveille JD, Vil? LM, Petri MA, Kimberly RP, Taylor KE, Criswell LA. Genetic risk factors for thrombosis in systemic lupus erythematosus. J Rheumatol. 2012 Aug; 39(8):1603-10.
    View in: PubMed
    Score: 0.009
  41. Santiago-Casas Y, Vil? LM, McGwin G, Cantor RS, Petri M, Ramsey-Goldman R, Reveille JD, Kimberly RP, Alarc?n GS, Brown EE. Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort. Arthritis Care Res (Hoboken). 2012 May; 64(5):704-12.
    View in: PubMed
    Score: 0.009
  42. Willis R, Seif AM, McGwin G, Martinez-Martinez LA, Gonz?lez EB, Dang N, Papalardo E, Liu J, Vil? LM, Reveille JD, Alarc?n GS, Pierangeli SS. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus. 2012 Jul; 21(8):830-5.
    View in: PubMed
    Score: 0.009
  43. Hughes T, Adler A, Kelly JA, Kaufman KM, Williams AH, Langefeld CD, Brown EE, Alarc?n GS, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Boackle SA, Stevens AM, Reveille JD, Sanchez E, Mart?n J, Niewold TB, Vil? LM, Scofield RH, Gilkeson GS, Gaffney PM, Criswell LA, Moser KL, Merrill JT, Jacob CO, Tsao BP, James JA, Vyse TJ, Alarc?n-Riquelme ME, Harley JB, Richardson BC, Sawalha AH. Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus. Arthritis Rheum. 2012 Feb; 64(2):485-92.
    View in: PubMed
    Score: 0.009
  44. Tan W, Sunahori K, Zhao J, Deng Y, Kaufman KM, Kelly JA, Langefeld CD, Williams AH, Comeau ME, Ziegler JT, Marion MC, Bae SC, Lee JH, Lee JS, Chang DM, Song YW, Yu CY, Kimberly RP, Edberg JC, Brown EE, Petri MA, Ramsey-Goldman R, Vil? LM, Reveille JD, Alarc?n-Riquelme ME, Harley JB, Boackle SA, Stevens AM, Scofield RH, Merrill JT, Freedman BI, Anaya JM, Criswell LA, Jacob CO, Vyse TJ, Niewold TB, Gaffney PM, Moser KL, Gilkeson GS, Kamen DL, James JA, Grossman JM, Hahn BH, Tsokos GC, Tsao BP, Alarc?n GS. Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. Arthritis Rheum. 2011 Sep; 63(9):2755-63.
    View in: PubMed
    Score: 0.009
  45. Sanchez E, Nadig A, Richardson BC, Freedman BI, Kaufman KM, Kelly JA, Niewold TB, Kamen DL, Gilkeson GS, Ziegler JT, Langefeld CD, Alarc?n GS, Edberg JC, Ramsey-Goldman R, Petri M, Brown EE, Kimberly RP, Reveille JD, Vil? LM, Merrill JT, Anaya JM, James JA, Pons-Estel BA, Martin J, Park SY, Bang SY, Bae SC, Moser KL, Vyse TJ, Criswell LA, Gaffney PM, Tsao BP, Jacob CO, Harley JB, Alarc?n-Riquelme ME, Sawalha AH. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis. 2011 Oct; 70(10):1752-7.
    View in: PubMed
    Score: 0.009
  46. Freedman BI, Edberg JC, Comeau ME, Murea M, Bowden DW, Divers J, Alarc?n GS, Brown EE, McGwin G, Kopp JB, Winkler CA, Nelson GW, Illei G, Petri M, Ramsey-Goldman R, Reveille JD, Vil? LM, Langefeld CD, Kimberly RP. The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans. Am J Nephrol. 2010; 32(1):66-72.
    View in: PubMed
    Score: 0.008
  47. Burgos PI, McGwin G, Reveille JD, Vil? LM, Alarc?n GS. Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII). Rheumatology (Oxford). 2010 Sep; 49(9):1720-5.
    View in: PubMed
    Score: 0.008
  48. Pons-Estel GJ, Alarc?n GS, Gonz?lez LA, Zhang J, Vil? LM, Reveille JD, McGwin G. Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort. Arthritis Care Res (Hoboken). 2010 Mar; 62(3):393-400.
    View in: PubMed
    Score: 0.008
  49. Pons-Estel GJ, Alarc?n GS, McGwin G, Danila MI, Zhang J, Bastian HM, Reveille JD, Vil? LM. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum. 2009 Jun 15; 61(6):830-9.
    View in: PubMed
    Score: 0.008
  50. Pons-Estel GJ, Gonz?lez LA, Zhang J, Burgos PI, Reveille JD, Vil? LM, Alarc?n GS. Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort. Rheumatology (Oxford). 2009 Jul; 48(7):817-22.
    View in: PubMed
    Score: 0.007
  51. Danila MI, Pons-Estel GJ, Zhang J, Vil? LM, Reveille JD, Alarc?n GS. Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. Rheumatology (Oxford). 2009 May; 48(5):542-5.
    View in: PubMed
    Score: 0.007
  52. Bertoli AM, Vil? LM, Reveille JD, Alarc?n GS. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage. J Rheumatol. 2008 Dec; 35(12):2355-8.
    View in: PubMed
    Score: 0.007
  53. Dur?n S, Apte M, Alarc?n GS, Marion MC, Edberg JC, Kimberly RP, Zhang J, Langefeld CD, Vil? LM, Reveille JD. Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort. Arthritis Rheum. 2008 Sep 15; 59(9):1332-40.
    View in: PubMed
    Score: 0.007
  54. Fern?ndez M, McGwin G, Andrade R, Bastian HM, Fessler BJ, Reveille JD, Vil? LM, Alarc?n GS. Systemic lupus erythematosus in a multiethnic US cohort, LUMINA (XLIX): preliminary evaluation of the impact of statins on disease activity. J Clin Rheumatol. 2008 Jun; 14(3):178-80.
    View in: PubMed
    Score: 0.007
  55. Fern?ndez M, Calvo-Al?n J, Bertoli AM, Bastian HM, Fessler BJ, McGwin G, Reveille JD, Vil? LM, Alarc?n GS. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women. J Clin Rheumatol. 2007 Oct; 13(5):261-5.
    View in: PubMed
    Score: 0.007
  56. Fern?ndez M, Alarc?n GS, McGwin G, Sanchez ML, Apte M, Vil? LM, Reveille JD. Using the Short Form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohort. Arthritis Rheum. 2007 Aug 15; 57(6):986-92.
    View in: PubMed
    Score: 0.007
  57. Chaiamnuay S, Bertoli AM, Fern?ndez M, Apte M, Vil? LM, Reveille JD, Alarc?n GS. The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected]. J Clin Rheumatol. 2007 Jun; 13(3):128-33.
    View in: PubMed
    Score: 0.007
  58. Fern?ndez M, Alarc?n GS, Calvo-Al?n J, Andrade R, McGwin G, Vil? LM, Reveille JD. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum. 2007 May 15; 57(4):576-84.
    View in: PubMed
    Score: 0.007
  59. Alarc?n GS, McGwin G, Bertoli AM, Fessler BJ, Calvo-Al?n J, Bastian HM, Vil? LM, Reveille JD. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis. 2007 Sep; 66(9):1168-72.
    View in: PubMed
    Score: 0.006
  60. Fern?ndez M, Alarc?n GS, Apte M, Andrade RM, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor. Arthritis Rheum. 2007 Feb; 56(2):614-21.
    View in: PubMed
    Score: 0.006
  61. Andrade RM, Alarc?n GS, Fern?ndez M, Apte M, Vil? LM, Reveille JD. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum. 2007 Feb; 56(2):622-30.
    View in: PubMed
    Score: 0.006
  62. Bertoli AM, Vila LM, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarcon GS. Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage. Lupus. 2007; 16(6):410-7.
    View in: PubMed
    Score: 0.006
  63. R?os-Olivares E, Vil? LM, Reyes JC, Rodr?guez JW, Col?n JH, Pag?n NO, Marrero A, R?os-Orraca ZM, Boukli NM, Shapshak P, Robles RR. Impaired cytokine production and suppressed lymphocyte proliferation activity in HCV-infected cocaine and heroin ("speedball") users. Drug Alcohol Depend. 2006 Dec 01; 85(3):236-43.
    View in: PubMed
    Score: 0.006
  64. Chaiamnuay S, Bertoli AM, Roseman JM, McGwin G, Apte M, Dur?n S, Vil? LM, Reveille JD, Alarc?n GS. African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV). Ann Rheum Dis. 2007 May; 66(5):618-22.
    View in: PubMed
    Score: 0.006
  65. Alarc?n GS, McGwin G, Petri M, Ramsey-Goldman R, Fessler BJ, Vil? LM, Edberg JC, Reveille JD, Kimberly RP. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med. 2006 Oct; 3(10):e396.
    View in: PubMed
    Score: 0.006
  66. Calvo-Al?n J, Alarc?n GS, Tew MB, Tan FK, McGwin G, Fessler BJ, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events. Arthritis Rheum. 2006 Jun; 54(6):1940-5.
    View in: PubMed
    Score: 0.006
  67. Bertoli AM, Alarc?n GS, Calvo-Al?n J, Fern?ndez M, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. Arthritis Rheum. 2006 May; 54(5):1580-7.
    View in: PubMed
    Score: 0.006
  68. Calvo-Al?n J, Toloza SM, Fern?ndez M, Bastian HM, Fessler BJ, Roseman JM, McGwin G, Vil? LM, Reveille JD, Alarc?n GS. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum. 2005 Jul; 52(7):2060-8.
    View in: PubMed
    Score: 0.006
  69. Fern?ndez M, Calvo-Al?n J, Alarc?n GS, Roseman JM, Bastian HM, Fessler BJ, McGwin G, Vil? LM, Sanchez ML, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women. Arthritis Rheum. 2005 Jun; 52(6):1655-64.
    View in: PubMed
    Score: 0.006
  70. Fessler BJ, Alarc?n GS, McGwin G, Roseman J, Bastian HM, Friedman AW, Baethge BA, Vil? L, Reveille JD. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum. 2005 May; 52(5):1473-80.
    View in: PubMed
    Score: 0.006
  71. Toloza SM, Uribe AG, McGwin G, Alarc?n GS, Fessler BJ, Bastian HM, Vil? LM, Wu R, Shoenfeld Y, Roseman JM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum. 2004 Dec; 50(12):3947-57.
    View in: PubMed
    Score: 0.005
  72. Uribe AG, Vil? LM, McGwin G, Sanchez ML, Reveille JD, Alarc?n GS. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol. 2004 Oct; 31(10):1934-40.
    View in: PubMed
    Score: 0.005
  73. Toloza SM, Roseman JM, Alarc?n GS, McGwin G, Uribe AG, Fessler BJ, Bastian HM, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage. Arthritis Rheum. 2004 Oct; 50(10):3177-86.
    View in: PubMed
    Score: 0.005
  74. Alarc?n GS, McGwin G, Roseman JM, Uribe A, Fessler BJ, Bastian HM, Friedman AW, Baethge B, Vil? LM, Reveille JD. Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis. Arthritis Rheum. 2004 Aug 15; 51(4):609-15.
    View in: PubMed
    Score: 0.005
  75. Alarc?n GS, McGwin G, Uribe A, Friedman AW, Roseman JM, Fessler BJ, Bastian HM, Baethge BA, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004 Jun 15; 51(3):465-74.
    View in: PubMed
    Score: 0.005
  76. Robles RR, Reyes JC, Col?n HM, Matos TD, Vil? P?rez L, Marrero CA. Prevalence and correlates of anergy among drug users in Puerto Rico. Int J Epidemiol. 1999 Jun; 28(3):509-13.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support